Holen Sie sich die Stockscreener-App
20.10
2.24%
0.44
Vorhandelsmarkt:
20.23
0.13
+0.65%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$19.66
Offen:
$19.5
24-Stunden-Volumen:
5.07M
Relative Volume:
0.67
Marktkapitalisierung:
$10.38B
Einnahmen:
$11.32B
Nettoeinkommen (Verlust:
$-981.00M
KGV:
-10.29
EPS:
-1.9532
Netto-Cashflow:
$714.00M
1W Leistung:
-1.76%
1M Leistung:
+4.80%
6M Leistung:
+6.18%
1J Leistung:
-32.98%
1-Tages-Spanne:
$19.42
$20.17
1-Wochen-Bereich:
$19.38
$20.62
52-Wochen-Spanne:
$15.73
$31.75
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
20.10 | 10.38B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
403.18 | 142.79B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
143.92 | 39.66B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.12 | 32.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
35.30 | 29.85B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
191.26 | 27.74B | 5.54B | 1.52B | 1.74B | 10.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Herabstufung | Argus | Buy → Hold |
| 2025-08-04 | Herabstufung | Stifel | Buy → Hold |
| 2025-08-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-02-26 | Fortgesetzt | Goldman | Buy |
| 2025-02-24 | Hochstufung | Argus | Hold → Buy |
| 2025-02-20 | Fortgesetzt | Barclays | Overweight |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Albireo Energy in Edison appoints Baxter as CEO - ROI-NJ
Baxter International focuses on dialysis and hospital portfolio, shares on NYSE under analyst watch - Ad-hoc-news.de
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact - Eagle-Tribune
Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare Challenges with a Potential 8.3% Upside - DirectorsTalk Interviews
Is Baxter International stock underperforming the S&P 500? - MSN
Baxter's unit Synovis MCA to lead global rollout of the SHIYA platform - MSN
Baxter International Stocklong-term strategy stays in focus after Vantive spin-off - Ad-hoc-news.de
Quietly crucial on the ward, Baxter’s Sigma Spectrum infusion pump in everyday use - AD HOC NEWS
Why Baxter’s Spectrum IQ smart pump is drawing fresh attention in hospitals - AD HOC NEWS
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform - Yahoo Finance
Business News - LatestLY
Quietly precise, Baxter Spectrum IQ aims to make IV pumps less stressful - AD HOC NEWS
Baxter International Inc (BAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Baxter International Inc (BAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Smart safety touches, Baxter Spectrum IQ pump aims for quieter hospital days - AD HOC NEWS
symbol__ Stock Quote Price and Forecast - CNN
MediThinQ partners with Baxter unit to distribute 3D platform - Investing.com
Baxter International Unit Signs Distribution Deal for Surgical Visualization Platform - Moomoo
MediThinQ partners with Baxter unit to distribute 3D platform By Investing.com - Investing.com India
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MSN
Baxter International Inc (BAX) Stock Down 5.2% -- Now Undervalued? GF Score: 60/100 - GuruFocus
Baxter International Inc (BAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Baxter International Inc (BAX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Baxter International Inc (BAX) Institutional Confidence - TradingKey
Baxter International Inc (BAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Baxter International Inc (BAX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Baxter International Inc (BAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is Baxter International Stock Underperforming the S&P 500? - Yahoo Finance
Baxter’s Post-Divestiture Profit Focus Might Change The Case For Investing In Baxter International (BAX) - simplywall.st
BAX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Baxter International Inc. Stock (US0673431090): Valuation and fundamentals in focus - AD HOC NEWS
Reasons to Retain Baxter International Stock in Your Portfolio for Now - Yahoo Finance
Baxter International stock outlook: Is Wall Street bullish or bearish? - MSN
Baxter International Inc. Stock (US0673431090): Analyst reiteration and modest NYSE move keep BAX in - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a Potential Upside - DirectorsTalk Interviews
Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted - Yahoo Finance
Baxter International Inc. Stock (US0673431090): Analyst reiteration and NYSE move keep healthcare na - AD HOC NEWS
Baxter International Inc. Stock (US0673431090): Analyst reiteration and recent price move in focus - AD HOC NEWS
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter (BAX) Has an Installed-Base-and-Margin-Reset Story Bigger Than a Turnaround Trade - AlphaStreet
Baxter International Inc Stock (US0718131099): Valuation metrics keep S&P 500 healthcare name in foc - AD HOC NEWS
Baxter International Inc. Stock (US0673431090): Earnings trends and valuation in focus - AD HOC NEWS
BofA Securities Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $24 - 富途牛牛
FMR LLC's Strategic Acquisition of Baxter International Inc. Sha - GuruFocus
Is Baxter International Inc. (BAX) A Good Stock To Buy Now? - Insider Monkey
Citi Downgrades Baxter International to Sell with Lower Price Target - HarianBasis.co
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges - GuruFocus
Baxter International (BAX) Faces Tough Road Ahead, Says Citi in Downgrade - Yahoo Finance
Baxter International Inc (BAX) Shares Surge 4.1% -- What GF Scor - GuruFocus
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.03%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):